Email this article Hhe results of different antibodies application for CD1a expression evaluation in pediatric t-lineage all
- Authors: Aksenova A.S.1, Illarionova O.I.1, Litvinov D.V.1, Kashpor S.A.1, Popov A.M.1
-
Affiliations:
- Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology Ministry of Healthcare of Russian Federation.
- Issue: Vol 17, No 4 (2018)
- Pages: 23-26
- Section: ORIGINAL ARTICLES
- Submitted: 10.01.2019
- Accepted: 10.01.2019
- Published: 10.01.2019
- URL: https://hemoncim.com/jour/article/view/209
- DOI: https://doi.org/10.24287/1726-1708-2018-17-4-23-26
- ID: 209
Cite item
Full Text
Abstract
CD1a antigen expression is an important prognostic factor in T-lineage acute lymphoblastic leukemia (T-ALL), thus standardized approach for this antigen expression detection is crucial for multicenter trials. The use of different antibodies in laboratories could lead to wrong decisions for patients management. The aim of the present study was to analyze the results of flow cytometric bone marrow investigation in children with T-ALL using different CD1a-directed antibodies. The bone marrow samples from 31 children (8 girls and 23 boys) with T-ALL aged from 1 to 16 years (median age 7) were studied by multicolor flow cytometry including two different antibodies against CD1a (BL6 и SK9). There were no significant differences in the immunophenotyping results. However, the CD1a-positivity of tumor cell population was visible in the dot plot better when BL6 antibody was used. In addition, two patients with discordant CD1a expression data were founded. Therefore, we antibody BL6 was recommended for routine T-ALL immunophenotyping.
Keywords
About the authors
A. S. Aksenova
Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology Ministry of Healthcare of Russian Federation.
Author for correspondence.
ORCID iD: 0000-0001-5354-7067
Russian Federation
O. I. Illarionova
Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology Ministry of Healthcare of Russian Federation.
ORCID iD: 0000-0003-2685-674X
Russian Federation
D. V. Litvinov
Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology Ministry of Healthcare of Russian Federation.
ORCID iD: 0000-0002-7461-0050
Russian Federation
S. A. Kashpor
Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology Ministry of Healthcare of Russian Federation.
ORCID iD: 0000-0002-5220-7412
Russian Federation
A. M. Popov
Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology Ministry of Healthcare of Russian Federation.
Email: uralcytometry@gmail.com
ORCID iD: 0000-0002-0889-6986
MD, PhD, Head of Cell immunology and immunogenesis laboratory.
117997, Moscow, Samory Mashela st., 1.
Russian FederationReferences
- Swerdlow S.H. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th Edition, IARC 2008.
- Зуева Е.Е., Куртова А.В., Русанова Е.Б. Диагностика онкогематологических заболеваний с помощью проточной цитометрии: справочник. – СПб.: СпецЛит, 2017.
- Луговская С.А., Почтарь М.Е. Гематологический атлас (4-е изд., доп.). – Москва–Тверь: ООО «Издательство «Триада», 2016.
- Chiaretti S., Foà R. T-cell acute lymphoblastic leukemia. Hematologica 2009; 94 (2): 160–2.
- Bene M.C., Castoldi G, Knapp W., Ludwig W.D., Matutes E., Orfao A., et al. Proposals for the immunological classification of acute leukemias. Leukemia 1995; 9: 1783–86.
- Babusikova O., Stevulova L., Fajto- va M. Immunophenotyping parameters as prognostic factors in T-acute leukemia patients. Neoplasma 2009; 56 (6): 508–13.
- Mugairi Dalal B.I., Pi S., Lee S.Y., Khare N.S., Pal J., Vakilet A., et al. Thymic Immunophenotype, and Expression of CD4 and Myeloid Antigens is Associated with Outcome in Adult Patients with T-сell Acute Lymphoblastic Leukemia. J Leuk 2015; 3 (1): 2–6.
- Marks D.I., Paietta E.M., Moorman A.V., Richards S.M., Buck G., DeWald G., et al. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). Blood 2009; 114 (25): 5136–45.
- Grotel van M., Meijerink J.P., van Wer- ing E.R., Langerak A.W., Beverloo H.B., Buijs-Gladdines J.G., et al. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. Leukemia 2008; 22: 124–31.
- Kalina T. Flores-Montero J., van der Velden V. H. J., Martin-Ayuso M., Bött- cher S., Ritgen M., et al. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia 2012; 26: 1986–2010.
- Новикова И.А., Вержбицкая Т.Ю., Мовчан Л.В. и др. Стандарт российско-белорусской кооперативной группы по иммунофенотипированию острого лимфобластного лейкоза у детей. Онкогематология 2018; 13 (1): 56–65.
Supplementary files
